Whole-body positron emission tomography in patients with HIV-1 infection

EANM/SNMMI Guideline for18F-FDG Use in Inflammation and Infection

“…• AIDS-associated opportunistic infections, associated tumors, and Castleman disease (72)(73)(74)(75)(76)(77)(78)(79)(80)(81)(82)(83).…”

FDG-PET Imaging in HIV Infection and Tuberculosis

“…In humans, Scharko et al 31 performed FDG-PET imaging in 15 patients suffering from HIV-1. They observed distinct lymphoid tissue activation in the head and neck during acute disease, a generalized pattern of peripheral LN activation at midstages, and involvement of abdominal LNs during late disease, suggesting that lymphoid tissues are engaged in a predictable sequence.…”

Necrotizing Cervical Lymphadenitis Caused by Mycobacterium simiae in an HIV-Positive Patient: Imaging with 18F-FDG PET/CT

“…Treatment includes surgical excision of the involved nodes and a course of antibiotics, although M. simiae is the most drug-resistant of all non-tuberculous mycobacteriae, requiring combination therapy [1]. 18 F-FDG PET/CT is proving to be a valuable tool for detecting and localizing various infectious disease processes in immunocompetent [3][4][5][6] as well as immunocompromised patients [7][8][9][10][11][12]. The role of 18 F-FDG PET/CT imaging in HIV patients continues to be investigated [7,8]; however, initial results for detecting HIV-related infections and malignancies are promising.…”

“…18 F-FDG PET/CT is proving to be a valuable tool for detecting and localizing various infectious disease processes in immunocompetent [3][4][5][6] as well as immunocompromised patients [7][8][9][10][11][12]. The role of 18 F-FDG PET/CT imaging in HIV patients continues to be investigated [7,8]; however, initial results for detecting HIV-related infections and malignancies are promising. Positive 18 F-FDG uptake in mycobacterial infections in immunocompromised hosts has been described for such mycobacterial species as: Mycobacterium tuberculosis, Mycobacterium avium intracellulare, Mycobacterium kansasii and Mycobacterium xenopi [9][10][11][12].…”